Can Mustang Bio Inc (NASDAQ: MBIO) Still Be Considered A Loss When It’s Up 105.48% YTD?

During the recent session, Mustang Bio Inc (NASDAQ:MBIO)’s traded shares were 44.67 million, with the beta value of the company hitting 1.77. At the last check today, the stock’s price was $0.36, reflecting an intraday gain of 105.48% or $0.18. The 52-week high for the MBIO share is $1.53, that puts it down -325.0 from that peak though still a striking 63.89% gain since the share price plummeted to a 52-week low of $0.13. The company’s market capitalization is $18.04M, and the average intraday trading volume over the past 10 days was 1.07 million shares, and the average trade volume was 1.91 million shares over the past three months.

Mustang Bio Inc (MBIO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. MBIO has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.16.

Mustang Bio Inc (NASDAQ:MBIO) trade information

Mustang Bio Inc (MBIO) registered a 105.48% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 105.48% in intraday trading to $0.36, hitting a weekly high. The stock’s 5-day price performance is 117.65%, and it has moved by 92.43% in 30 days. Based on these gigs, the overall price performance for the year is -72.45%. The short interest in Mustang Bio Inc (NASDAQ:MBIO) is 0.37 million shares and it means that shorts have 0.61 day(s) to cover.

Mustang Bio Inc (MBIO) estimates and forecasts

Statistics show that Mustang Bio Inc has outperformed its competitors in share price, compared to the industry in which it operates. Mustang Bio Inc (MBIO) shares have gone down -25.24% during the last six months, with a year-to-date growth rate more than the industry average at 86.50% against 16.70.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.87%.

MBIO Dividends

Mustang Bio Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.